ROCKVILLE, Md.--(BUSINESS WIRE)--KAI Research, Inc. (KAI), a wholly owned subsidiary of Altarum Institute, announced today that the Centers for Disease Control and Prevention (CDC) awarded it a contract to evaluate samples of pediatric, adult, and elderly individuals’ serum levels after flu vaccination to determine whether antibodies induced by the current vaccine effectively inhibit circulating influenza viruses. This project is part of CDC’s surveillance effort, with the potential to continue up to 5 years.
KAI is a full-service Contract Research Organization providing support to both government and commercial clients, including protocol review, regulatory tracking, monitoring, site management, safety monitoring, pharmacovigilance, data management, and statistical analysis support.
Help employers find you! Check out all the jobs and post your resume.
